Alkermes' Corporate Presentation To Be Webcast At The Credit Suisse 25th Annual Healthcare Conference

Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Credit Suisse 25 th Annual Healthcare Conference on Tuesday, Nov. 8, 2016, at 9:30 a.m. MT (11:30 a.m. ET/4:30 p.m. GMT) from The Phoenician in Scottsdale, AZ. The presentation may be accessed under the Investors tab on and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at

View source version on

Copyright Business Wire 2010